Last updated: May 12, 2026, 12:00 AM

Summit Therapeutics PLC Exchange (NASDAQ, USD)

SMMT

17.54
-0.43 (-2.02%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-13.60%
3 year return (CAGR)
139.83%
5 year return (CAGR)
29.45%
10 year return (CAGR)
11.52%
Stock Analysis

Computer Modeling Group 2027 Q1 - Turnarounds seldom turn?

Read More
Marketcap
16.17B
Price/Sales
-
Ent value
16.16B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open21.61
Daily high21.61
Daily low20.55
Daily Volume2.72M
All-time high36.70
1y analyst estimate28.49
Beta-1.24
EPS (TTM)-1.10
Dividend per share0.00
Ex-div date-
Next earnings date12 Mar 2026

Ready to capitalize on Summit Therapeutics PLC's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
SMMTS&P500
Current price drop from All-time high-52.21%-1.99%
Highest price drop-95.75%-56.47%
Date of highest drop1 Dec 20229 Mar 2009
Avg drop from high-57.82%-10.69%
Avg time to new high121 days12 days
Max time to new high1758 days1805 days